0800 822 3370
Registered charity number: SC032343
We also intend to encourage research into the causes of oesophageal cancer and to develop information and support services for patients and their families. Upper gastrointestinal cancers are classically detected as advanced tumours and as such have a poor prognosis. A five-year survival rate of only 6% is achieved even with use of radiotherapy and surgery; as such, oesophageal cancer is now the fourth highest cancer killer in the UK and causes around 4,000 deaths each year. There is at present little dedicated research into the causes of oesophageal cancer or ways in which earlier diagnosis can be made.
Ochre is attempting to change this situation and has recently been instrumental in the purchase of a state-of-the-art LIFE-GI (light-induced-fluorescence-endoscopy) system, now in operation at Gartnavel General Hospital in Glasgow.The system, costing £39,000, is capable of detecting cancerous cells at a very early stage, thereby offering vastly improved chances of survival to oesophageal cancer patients.